Skip to content
Billionaire Profile
Kiran Mazumdar-Shaw
Global Rank
#1288

Image: Prathyush Thomas | GFDL 1.2 | via Wikimedia Commons

Kiran Mazumdar-Shaw

CEO, Biopharmaceuticals
Bengaluru, India
Real-Time Net Worth
$3.35B
Estimated based on Biopharmaceuticals stock value as of September 10, 2026
+0.55% (24h)
Age
73
Source
Biopharmaceuticals
Industry
Healthcare
Citizenship
India

Biography

Kiran Mazumdar-Shaw, born in 1953, is an Indian billionaire entrepreneur and the Executive Chairperson of Biocon Limited and Biocon Biologics Limited. Her source of wealth stems from her pioneering work in biopharmaceuticals. With a career spanning over four decades, she transformed Biocon from an industrial enzymes manufacturer into a leading biopharmaceutical company focused on accessible and affordable medicines. Her achievements have earned her recognition as a global business leader and a champion of healthcare innovation. With a net worth of $3.5 billion in 2024, she continues to drive advancements in the healthcare industry and contribute significantly to philanthropic causes.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$3.35B
2025$3.50B
2024$3.50B

Portfolio Holdings

Biocon Limited

Biocon Limited

BIONhealthcare
Market Cap
$6.35B
Stock Price
$3.92
Revenue
$1.91B
Bengaluru, India
11,000+ employees
Founded 1978

In-Depth Profile

Early Life and Education

Kiran Mazumdar-Shaw was born on March 23, 1953, in Bangalore, India. She completed her schooling at Bishop Cotton Girl's High School and earned a bachelor's degree in Zoology from Bangalore University in 1973. She furthered her education by obtaining a master's degree in brewing from Ballarat University in Australia in 1975. Despite initially planning a career in medicine, she was unable to secure a scholarship and instead pursued her interest in brewing science.

Rise to Success

Kiran Mazumdar-Shaw founded Biocon India in 1978 with a modest capital of ₹10,000. Initially focusing on industrial enzymes, she steered the company into the biopharmaceuticals sector. She spearheaded the company's growth, making Biocon the first biotechnology company in India to launch an IPO. Her strategic vision and innovative approach led to the development of affordable medicines, establishing her as a prominent figure in the biotech industry.

Key Business Strategies

Kiran Mazumdar-Shaw's business strategies centered on innovation, research, and strategic partnerships. She transformed Biocon into a fully integrated biopharmaceutical company with a diversified portfolio of products. She established subsidiaries like Syngene and Clinigene (later merged) to support research and clinical trials. Her focus on biosimilars and affordable innovation has been key to Biocon's success, allowing it to reach over 21 million patients across 120 countries as of FY25.

Philanthropy

Kiran Mazumdar-Shaw is committed to philanthropic endeavors, particularly in healthcare. She established the Biocon Foundation, which focuses on health, education, and infrastructure in rural areas. She has also founded the Mazumdar-Shaw Medical Foundation, which supports cancer research and treatment. In 2015, she signed the Giving Pledge, committing to donate a significant portion of her wealth to philanthropic causes. She believes in affordable healthcare and is working to improve the lives of people through affordable innovation.

Career Milestones

1978

Founded Biocon India

Established Biocon, focusing on industrial enzymes and later biopharmaceuticals.

1989

Padma Shri Award

Awarded Padma Shri by the Indian government for her contributions to industrial biotechnology.

2004

Biocon IPO

Successfully listed Biocon on the stock market.

2005

Padma Bhushan Award

Awarded Padma Bhushan for her pioneering work in industrial biotechnology.

2020

EY World Entrepreneur Of The Year

Recognized as EY World Entrepreneur Of The Year.

Philanthropy & Social Impact

Health, Education, Infrastructure

Biocon Foundation

$33M (cumulative)

Focuses on health, education, and infrastructure, especially in rural areas.

Healthcare

Mazumdar-Shaw Medical Foundation

Undisclosed

Supports cancer research and treatment.

Education

Mazumdar-Shaw Scholarship Fund

1M

Provide scholarships to students pursuing careers in community medicine.

Business Philosophy & Leadership

Notable Quotes

"I really believe that entrepreneurship is about being able to face failure, manage failure and succeed after failing."

"I want to be remembered as someone who put India on the scientific map of the world in terms of large innovation."

"My legacy is going to be in affordable health care."

Leadership Principles

Innovation

Focusing on creating new and improved products and processes.

Affordable Healthcare

Making healthcare accessible and affordable to a wide range of people.

Philanthropy

Giving back to society through healthcare and education initiatives.

Billionaires Connected to Kiran Mazumdar-Shaw

Peers in Healthcare

All Healthcare billionaires

Richest in India

All billionaires from India

Adjacent Global Ranks

Full global ranking

Frequently Asked Questions

What is Kiran Mazumdar-Shaw's net worth in 2026?
As of 2026, Kiran Mazumdar-Shaw's estimated net worth is $3.352 billion, ranking #1288 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Kiran Mazumdar-Shaw make their money?
Kiran Mazumdar-Shaw's wealth primarily comes from Biopharmaceuticals, most notably through Biopharmaceuticals.
Where is Kiran Mazumdar-Shaw from?
Kiran Mazumdar-Shaw is from India.
How old is Kiran Mazumdar-Shaw?
Kiran Mazumdar-Shaw is 73 years old.

Sources & References

  1. Kiran Mazumdar-Shaw — Forbes profile Forbes